Logothetis CJ - Search Results

1

Germ cell tumors in patients infected by the human immunodeficiency virus.

Fizazi K, Amato RJ, Beuzeboc P, Petit N, Bouhour D, Thiss A, Rebischung C, Chevreau C, Logothetis CJ, Droz JP. Fizazi K, et al. Among authors: logothetis cj. Cancer. 2001 Sep 15;92(6):1460-7. doi: 10.1002/1097-0142(20010915)92:6<1460::aid-cncr1470>3.0.co;2-i. Cancer. 2001. PMID: 11745223

2

Chemotherapy for small cell carcinoma of prostatic origin.

Amato RJ, Logothetis CJ, Hallinan R, Ro JY, Sella A, Dexeus FH. Amato RJ, et al. Among authors: logothetis cj. J Urol. 1992 Mar;147(3 Pt 2):935-7. doi: 10.1016/s0022-5347(17)37427-x. J Urol. 1992. PMID: 1311396

3

Dose intensity in germ cell tumors: lessons learned?

Logothetis CJ, Amato RJ. Logothetis CJ, et al. J Natl Cancer Inst. 1992 Nov 18;84(22):1686-7. doi: 10.1093/jnci/84.22.1686. J Natl Cancer Inst. 1992. PMID: 1331481 No abstract available.

4

Predictive factors for effective salvage therapy of nonseminomatous germ cell tumors of testis.

Dimopoulos MA, Amato RJ, Logothetis CJ. Dimopoulos MA, et al. Among authors: logothetis cj. Urology. 1991 Oct;38(4):351-4. doi: 10.1016/0090-4295(91)80151-v. Urology. 1991. PMID: 1661457

5

Evidence of malignant features in histologically mature teratoma.

Sella A, el Naggar A, Ro JY, Dexeus FH, Amato RJ, Lee JS, Finn L, Logothetis CJ. Sella A, et al. Among authors: logothetis cj. J Urol. 1991 Oct;146(4):1025-8. doi: 10.1016/s0022-5347(17)37993-4. J Urol. 1991. PMID: 1680200

6

Fluorouracil and recombinant human interferon alfa-2a in the treatment of metastatic chemotherapy-refractory urothelial tumors.

Logothetis CJ, Hossan E, Sella A, Dexeus FH, Amato RJ. Logothetis CJ, et al. J Natl Cancer Inst. 1991 Feb 20;83(4):285-8. doi: 10.1093/jnci/83.4.285. J Natl Cancer Inst. 1991. PMID: 1994058 Clinical Trial.

7

Chemotherapy immediately after surgery for patients with germ cell tumors.

Sella A, Logothetis CJ, Dexeus FH, Amato R. Sella A, et al. Among authors: logothetis cj. Urology. 1990 Sep;36(3):264-6. doi: 10.1016/0090-4295(90)80270-w. Urology. 1990. PMID: 2168105

8

Escalated therapy for refractory urothelial tumors: methotrexate-vinblastine-doxorubicin-cisplatin plus unglycosylated recombinant human granulocyte-macrophage colony-stimulating factor.

Logothetis CJ, Dexeus FH, Sella A, Amato RJ, Kilbourn RG, Finn L, Gutterman JU. Logothetis CJ, et al. J Natl Cancer Inst. 1990 Apr 18;82(8):667-72. doi: 10.1093/jnci/82.8.667. J Natl Cancer Inst. 1990. PMID: 2181151

9

A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors.

Logothetis CJ, Dexeus FH, Finn L, Sella A, Amato RJ, Ayala AG, Kilbourn RG. Logothetis CJ, et al. J Clin Oncol. 1990 Jun;8(6):1050-5. doi: 10.1200/JCO.1990.8.6.1050. J Clin Oncol. 1990. PMID: 2189954 Clinical Trial.

10

Escalated MVAC with or without recombinant human granulocyte-macrophage colony-stimulating factor for the initial treatment of advanced malignant urothelial tumors: results of a randomized trial.

Logothetis CJ, Finn LD, Smith T, Kilbourn RG, Ellerhorst JA, Zukiwski AA, Sella A, Tu SM, Amato RJ. Logothetis CJ, et al. J Clin Oncol. 1995 Sep;13(9):2272-7. doi: 10.1200/JCO.1995.13.9.2272. J Clin Oncol. 1995. PMID: 7666085 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

408 results

Search Page